Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 4

2(33.3%)

Phase 3

2(33.3%)

6Total

N/A(2)

Phase 4(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02231086Phase 3Completed

Adjuvant HIPEC in High Risk Colon Cancer

Role: collaborator

NCT02064335Not ApplicableCompleted

Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons

Role: collaborator

NCT00189098Not ApplicableCompleted

Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media

Role: collaborator

NCT00434200Phase 4Unknown

Rheumatoid Arthritis Patients in Training

Role: collaborator

NCT00138983Phase 3Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

Role: collaborator

NCT00273676Phase 4Completed

Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia

Role: collaborator

All 6 trials loaded